Second Chance at Life Act of 2025

This federal bill requires abortion providers to inform patients about potential reversal of mifepristone-based chemical abortions (the two-drug process) at least 24 hours before the procedure. After the first drug is dispensed, providers must give written instructions stating that reversal may be possible if the second pill hasn't been taken. Facilities must post visible signs about reversal options, and the government must maintain a website with reversal resources. Violations allow affected patients or family members to sue for damages.